Lack of correlation between the alpha-tocopherol content of plasma and LDL, but high correlations for gamma-tocopherol and carotenoids.

In 59 healthy human subjects (37 male and 22 female) the concentrations of the lipid-soluble antioxidants alpha- and gamma-tocopherol, alpha- and beta-carotene, lycopene, cryptoxanthin, canthaxanthin, and lutein + zeaxanthin were determined in plasma (mumol/L) and in isolated low density lipoproteins (LDL) (mumol/mmol cholesterol). Plasma alpha-tocopherol concentrations were significantly correlated with plasma total cholesterol concentrations (r2 = 0.51, P < 0.0001) yet not with the LDL alpha-tocopherol content (r2 = 0.05, ns). Plasma gamma-tocopherol concentrations were weakly correlated with plasma total cholesterol (r2 = 0.12, P < 0.003) and both absolute and cholesterol standardized plasma gamma-tocopherol concentrations correlated strongly with the LDL gamma-tocopherol content (r2 = 0.58 and r2 = 0.72, respectively). In contrast, carotenoid concentrations did not correlate with cholesterol concentrations, but their LDL content correlated significantly with the respective plasma concentrations (r2 = 0.67 to 0.92, all P < 0.0001). In a subgroup of study subjects (n = 13) the distribution of vitamin E and carotenoids among LDL was calculated. The proportion of plasma alpha- and gamma-tocopherol found in LDL was 48 +/- 7 (range, 36-61%) and 41 +/- 7%, respectively, suggesting that LDL was in most of these subjects not the main carrier for these antioxidants. The lipophilic carotenoids, however, were predominantly carried by LDL (e.g., beta-carotene: 87 +/- 10%), whereas the proportion of the more polar ones carried by LDL was much smaller (e.g., lutein + zeaxanthin: 36 +/- 6%). The results of this study show that plasma alpha-tocopherol concentrations are not predictive for the alpha-tocopherol content of LDL in nonsupplemented individuals. This finding could have implications in interpreting the cause of the inverse relationship between plasma alpha-tocopherol and risk of atherosclerosis.

[1]  M. V. van’t Hof,et al.  Impaired resistance to oxidation of low density lipoprotein in cystic fibrosis: improvement during vitamin E supplementation. , 1995, Free radical biology & medicine.

[2]  J. E. Romanchik,et al.  Distributions of carotenoids and alpha-tocopherol among lipoproteins do not change when human plasma is incubated in vitro. , 1995, The Journal of nutrition.

[3]  S. Gieseg,et al.  Effect of temperature and phase transition on oxidation resistance of low density lipoprotein. , 1995, Journal of lipid research.

[4]  D. Steinberg.  Clinical trials of antioxidants in atherosclerosis: are we doing the right thing? , 1995, The Lancet.

[5]  A. Azzi,et al.  Tocopherols and 6-hydroxy-chroman-2-carbonitrile derivatives inhibit vascular smooth muscle cell proliferation by a nonantioxidant mechanism. , 1995, Archives of biochemistry and biophysics.

[6]  M. V. van’t Hof,et al.  Enhanced resistance to oxidation of low density lipoproteins and decreased lipid peroxide formation during beta-carotene supplementation in cystic fibrosis. , 1995, Free radical biology & medicine.

[7]  V. V. van Hinsbergh,et al.  Supplementation with low doses of vitamin E protects LDL from lipid peroxidation in men and women. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[8]  M. Jauhiainen,et al.  Human plasma phospholipid transfer protein accelerates exchange/transfer of alpha-tocopherol between lipoproteins and cells. , 1995, The Biochemical journal.

[9]  R. Salkeld,et al.  Serum Antioxidants and Myocardial Infarction: Are Low Levels of Carotenoids and α‐ Tocopherol Risk Factors for Myocardial Infarction? , 1994, Circulation.

[10]  C. A. de la Motte,et al.  Alpha-tocopherol inhibits agonist-induced monocytic cell adhesion to cultured human endothelial cells. , 1994, The Journal of clinical investigation.

[11]  P. Reaven,et al.  Susceptibility of human LDL to oxidative modification. Effects of variations in beta-carotene concentration and oxygen tension. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[12]  F. Granado,et al.  Seasonal and sex-related variations in six serum carotenoids, retinol, and alpha-tocopherol. , 1994, The American journal of clinical nutrition.

[13]  S. Caudill,et al.  Retinol, alpha-tocopherol, lutein/zeaxanthin, beta-cryptoxanthin, lycopene, alpha-carotene, trans-beta-carotene, and four retinyl esters in serum determined simultaneously by reversed-phase HPLC with multiwavelength detection. , 1994, Clinical chemistry.

[14]  J. Gaziano,et al.  Content of antioxidants, preformed lipid hydroperoxides, and cholesterol as predictors of the susceptibility of human LDL to metal ion-dependent and -independent oxidation. , 1993, Journal of lipid research.

[15]  R. Stocker,et al.  Tocopherol-mediated peroxidation. The prooxidant effect of vitamin E on the radical-initiated oxidation of human low-density lipoprotein , 1993 .

[16]  J. Manson,et al.  Vitamin E consumption and the risk of coronary disease in women. , 1993, The New England journal of medicine.

[17]  E. Rimm,et al.  Vitamin E consumption and the risk of coronary heart disease in men. , 1993, The New England journal of medicine.

[18]  M. Traber,et al.  Absorption, lipoprotein transport, and regulation of plasma concentrations of vitamin E in humans. , 1993, Journal of lipid research.

[19]  E. Bruckert,et al.  Dense low density lipoprotein subspecies with diminished oxidative resistance predominate in combined hyperlipidemia. , 1993, Journal of lipid research.

[20]  B. Clevidence,et al.  Association of carotenoids with human plasma lipoproteins. , 1993, Methods in enzymology.

[21]  H. Esterbauer,et al.  Lipid peroxidation and its role in atherosclerosis. , 1993, British medical bulletin.

[22]  J. Schlechte.  Supplementation with Vitamin E but Not Beta-Carotene in Vivo Protects Low Density Lipoprotein from Lipid Peroxidation in Vitro , 1992 .

[23]  H. Esterbauer,et al.  The role of lipid peroxidation and antioxidants in oxidative modification of LDL. , 1992, Free radical biology & medicine.

[24]  W. Stahl,et al.  Antioxidant Functions of Vitamins , 1992, Annals of the New York Academy of Sciences.

[25]  S. Grundy,et al.  Effect of dietary supplementation with alpha-tocopherol on the oxidative modification of low density lipoprotein. , 1992, Journal of lipid research.

[26]  H. Esterbauer,et al.  Effect of oral supplementation with D-alpha-tocopherol on the vitamin E content of human low density lipoproteins and resistance to oxidation. , 1991, Journal of lipid research.

[27]  P. Puska,et al.  Plasma Vitamins E and A Inversely Correlated to Mortality from Ischemic Heart Disease in Cross‐Cultural Epidemiology , 1989, Annals of the New York Academy of Sciences.

[28]  J L Witztum,et al.  Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. , 1989, The New England journal of medicine.

[29]  M. Mino,et al.  Distribution of tocopherol among human plasma lipoproteins. , 1988, Clinica chimica acta; international journal of clinical chemistry.

[30]  P. Richardson,et al.  Reduction of platelet adhesiveness by vitamin E supplementation in humans. , 1988, Thrombosis research.

[31]  R. D. Situnayake,et al.  The Use of Different Lipids to Express Serum Tocopherol: Lipid Ratios for the Measurement of Vitamin E Status , 1986, Annals of clinical biochemistry.

[32]  J. B. Massey,et al.  Kinetics of transfer of α-tocopherol between model and native plasma lipoproteins , 1984 .

[33]  J. Thompson,et al.  Distribution of alpha-tocopherol in human plasma lipoproteins. , 1982, The American journal of clinical nutrition.

[34]  E. Miller,et al.  The transport of alpha-tocopherol and beta-carotene in human blood. , 1976, Journal of lipid research.

[35]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.

[36]  N. Krinsky,et al.  The transport of vitamin A and carotenoids in human plasma. , 1958, Archives of biochemistry and biophysics.